Authors
Loading...
This review discusses gut microbiota's role in insulin resistance and metabolic dysregulation in T2DM, suggesting potential therapeutic interventions.
Jidda et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: